Joseph S. Konowiecki - 07 Nov 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role: Chairman of the Board, Director
Signature: /s/ Richard A. Cross, as Attorney-in-Fact, for Joseph S. Konowiecki
Issuer symbol: ALHC
Transactions as of: 07 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Nov 2022, 15:05:19 UTC
Previous filing: 10 Mar 2022
Next filing: 10 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALHC	Common Stock	Award	$0	+53,906	+6.2%	$0.000000	918,903	07 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALHC	Options (Right to Buy)	Award	$0	+35,817		$0.000000	35,817	07 Nov 2022	Common Stock	35,817	$12.25	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 53,906 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company).
F2	Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Content

Represents 53,906 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company).

Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.